MMSI - Merit Medical Systems, Inc.
| Previous Close | 55.78 |
| Open | 55.72 |
| Bid | 55.07 x 800 |
| Ask | 55.16 x 1000 |
| Day's Range | 54.93 - 56.78 |
| 52 Week Range | 49.40 - 66.34 |
| Volume | 170,407 |
| Avg. Volume | 378,295 |
| Market Cap | 3.023B |
| Beta (3Y Monthly) | 1.33 |
| PE Ratio (TTM) | 70.27 |
| EPS (TTM) | 0.78 |
| Earnings Date | Jul 25, 2019 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 69.38 |
- Zacks•yesterday
Merit Medical (MMSI) Earnings Expected to Grow: Should You Buy?
Merit Medical (MMSI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Simply Wall St.•yesterday
Should You Be Worried About Merit Medical Systems, Inc.'s (NASDAQ:MMSI) 4.6% Return On Equity?
While some investors are already well versed in financial metrics (hat tip), this article is for those who would like...
- GlobeNewswire•10 days ago
Merit Medical Systems to Announce Second Quarter Results on July 25, 2019
SOUTH JORDAN, Utah, July 09, 2019 -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in.
- Simply Wall St.•18 days ago
Have Insiders Been Selling Merit Medical Systems, Inc. (NASDAQ:MMSI) Shares?
It is not uncommon to see companies perform well in the years after insiders buy shares. The flip side of that is that...
- Insider Monkey•22 days ago
Is Merit Medical Systems, Inc. (MMSI) A Good Stock To Buy?
Hedge Funds and other institutional investors have just completed filing their 13Fs with the Securities and Exchange Commission, revealing their equity portfolios as of the end of March. At Insider Monkey, we follow nearly 750 active hedge funds and notable investors and by analyzing their 13F filings, we can determine the stocks that they are […]
- Zacks•25 days ago
Will Pharmacy International Hit Walgreens (WBA) Q3 Earnings?
Challenging market conditions, especially in retail, causes a slowdown in the Retail Pharmacy International division at Walgreens Boots (WBA).
- American City Business Journals•last month
SA biotech encounters more regulatory hurdles to U.S. market than in Europe
Nearly three years after taking its novel medical device to market in Europe, the Alamo City company is still working to clear U.S. regulatory roadblocks.
- Zacks•last month
HSIC vs. MMSI: Which Stock Is the Better Value Option?
HSIC vs. MMSI: Which Stock Is the Better Value Option?
- Zacks•last month
Merit Medical Acquires Brightwater Medical for $35 Million
The Brightwater Medical-acquisition broadens Merit Medical's (MMSI) product offerings.
- GlobeNewswire•last month
Merit Medical Acquires Brightwater Medical, Inc.
Brightwater Medical was founded by Dr. Robert Smouse, Professor of Radiology and Surgery, University of Illinois College of Medicine. Its primary product, the ConvertX®, is a single device used to replace a series of devices and procedures used to treat severe obstructions of the ureter. The system is designed to be implanted once and converted from a nephroureteral catheter to a nephroureteral stent without requiring sedation or local anesthesia. Brightwater Medical recently received FDA clearance for the ConvertX® biliary stent system. Over the next several months, Merit Medical intends to maintain Brightwater Medical’s production capabilities in Temecula while duplicating those capabilities in its catheter facility in Pearland, Texas, prior to transferring the ConvertX® manufacturing operations to its Pearland facility. Merit Medical’s management estimates that the transaction will be approximately $(0.05) decretive to earnings per share for the year ending December 31, 2019 on a GAAP basis and approximately $(0.03) decretive to earnings per share for the year ending December 31, 2019 on a non-GAAP basis due to deal-related expenses, severance, transfer and integration costs, and international regulatory expenses. Management’s current revenue expectations for the ConvertX® product for calendar year 2019 are approximately $1 million with expectations of growth to approximately $25 million in the fifth full year of sales. Upon transfer of the ConvertX® manufacturing operations to Merit’s Pearland facility, management believes non-GAAP gross margins in the 70-75% range are attainable.
- Simply Wall St.•last month
The Merit Medical Systems (NASDAQ:MMSI) Share Price Has Soared 304%, Delighting Many Shareholders
Long term investing can be life changing when you buy and hold the truly great businesses. While the best companies...
- Markit•last month
See what the IHS Markit Score report has to say about Merit Medical Systems Inc.
Merit Medical Systems Inc NASDAQ/NGS:MMSIView full report here! Summary * Bearish sentiment is low * Economic output for the sector is expanding but at a slower rate Bearish sentimentShort interest | PositiveShort interest is low for MMSI with fewer than 5% of shares on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Money flowETF/Index ownership | NeutralETF activity is neutral. ETFs that hold MMSI had net inflows of $1.11 billion over the last one-month. Economic sentimentPMI by IHS Markit | NegativeAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is weak relative to the trend shown over the past year, however, and is easing. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to score@ihsmarkit.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
- GlobeNewswire•last month
Merit Medical Awarded Interventional Fluid Management Agreement With Premier
Merit Medical Systems, Inc. (MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy, announced today that it has been awarded a group purchasing agreement for interventional fluid management products with Premier. Effective July 1, 2019, this agreement provides for Premier members, at their discretion, to take advantage of negotiated commercial terms for Merit’s interventional fluid management portfolio of products. “Since our inception, our interventional fluid management products have been foundational to Merit's success and a key driver of our progress,” said Fred P. Lampropoulos, Merit Chairman and CEO.
- GlobeNewswire•last month
Merit Medical to Present at Raymond James Conference
SOUTH JORDAN, Utah, June 10, 2019 -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional,.
- Zacks•last month
Merit Medical Systems Sees Hammer Chart Pattern: Time to Buy?
Merit Medical Systems has been struggling lately, but the selling pressure may be coming to an end soon.
- Simply Wall St.•2 months ago
Merit Medical Systems, Inc. (NASDAQ:MMSI): Time For A Financial Health Check
Small-cap and large-cap companies receive a lot of attention from investors, but mid-cap stocks like Merit Medical...
- Zacks•2 months ago
Here's Why You Should Bet on Merit Medical (MMSI) Stock Now
Merit Medical (MMSI) continues to benefit from solid product pipeline, HeRO product line and persistent focus on R&D.
- Zacks•2 months ago
Merit Medical (MMSI) Down 4.4% Since Last Earnings Report: Can It Rebound?
Merit Medical (MMSI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
- MoneyShow•2 months ago
This Medical Firm Merits Attention
Merit Medical Systems (MMSI), founded in 1987 by current CEO Fred Lampropoulos, is a leading manufacturer and marketer of proprietary disposable medical devices, notes growth stock expert Hilary Kramer, editor of GameChangers.
- Zacks•2 months ago
Should You Invest in the Invesco S&P SmallCap Health Care ETF (PSCH)?
Sector ETF report for PSCH
- Simply Wall St.•2 months ago
What Kind Of Share Price Volatility Should You Expect For Merit Medical Systems, Inc. (NASDAQ:MMSI)?
Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! Anyone researching Merit Medical Systems, Inc. (NASDAQ:MMSI) might want to consider the historical vo...
